We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 290

Import Ban Quashed, and Health Canada Ordered to Retract Its Statements re Same
  • Borden Ladner Gervais LLP
  • Canada
  • January 13 2016

Apotex et al brought a judicial review of the Minister of Health's (the Minister) decision to impose an import ban on products from two of Apotex'


IP Update - 4th Quarter 2015
  • Marks & Clerk
  • Australia, Canada, China, European Union, Malaysia, Singapore, United Kingdom
  • December 16 2015

The unitary Community Trade Mark (CTM) was introduced in 1996. Since then, there have been no major changes to the system. However, the IP landscape


TPP: new rights for pharmaceutical patent holders
  • Gowling Lafleur Henderson LLP
  • Canada
  • December 9 2015

On November 5 2015 the Canadian government released the official consolidated text of the Trans-Pacific Partnership (TPP). This follows the technical


The TPP new rights for pharmaceutical patent holders in Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • November 13 2015

The Canadian Government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015. This follows the


The Trans-Pacific partnership: changes for patents and pharmaceuticals?
  • Gowling Lafleur Henderson LLP
  • Asia-Pacific, Canada
  • October 8 2015

Changes may be on the horizon for Canada’s legal and regulatory regime for patents and pharmaceuticals. Included in the Trans-Pacific Partnership


Canadian patent term extension the treaty text is released
  • Bereskin & Parr LLP
  • Canada
  • December 2 2014

Canada and Europe announced in October 2013, an agreement in principle on a Comprehensive Economic and Trade Agreement (CETA). Its most significant


Patent term restoration for Canadian pharmaceutical patents
  • Norton Rose Fulbright LLP
  • European Union, Canada
  • November 28 2014

The signature of the free-trade agreement texts between Canada and the European Union provided additional details on the provisions relating to the


Canada-EU Comprehensive Economic and Trade Agreement negotiation completed: additional protection for innovative pharmaceutical products
  • Fasken Martineau DuMoulin LLP
  • Canada, European Union
  • October 1 2014

On September 26, 2014, Canada and the EU announced completion of negotiations on the Canada-EU Comprehensive Economic and Trade Agreement (CETA


Canadian patent term extension draft treaty
  • Bereskin & Parr LLP
  • Canada, European Union
  • August 15 2014

Canada and Europe announced in October 2013, an agreement in principle on a Comprehensive Economic and Trade Agreement ("CETA"). Its most significant


Canada-EU free trade deal: intellectual property issues for the pharmaceutical industry
  • Dentons
  • Canada, European Union
  • October 24 2013

Canada and the European Union (the "EU") have signed a tentative deal to open markets and drop nearly all import taxes on everything from food to